AKBA
#3182
Akebia Therapeutics, Inc. - Common Stock
1.3 7 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.74%
Monthly Change
+44.21%
6 month change
+16.10%
Year Change
+16.10%
Previous Close
1.3 6
Open
1.3 5
Low
1.3 3
High
1.3 7
Volume
189
Financials
- Market Capitalization 367.51 M
- Employee 194
- Founded 2007
- CEO N/A
- Website www.akebia.com
- Headquarter Delaware, United States
- FIGI BBG000R33R00
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-80.5
Price to sales ratio
1.75
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3065 |  KMDA Kamada Ltd. - Ordinary Shares | 7.34 USD | +0.41% | -4.30% | +0.82% | -5.29% | 423.42 M USD | ||
| 3105 |  CGC Canopy Growth Corporation - Common Shares | 0.96 USD | +1.05% | +1.05% | -5.88% | -23.20% | 405.27 M USD | ||
| 3288 |  ORGO Organogenesis Holdings Inc. - Class A | 2.46 USD | -1.60% | +2.93% | +3.36% | -42.66% | 316.54 M USD | ||
| 3396 |  TKNO Alpha Teknova, Inc. - Common Stock | 5.07 USD | -6.63% | -13.18% | +9.03% | +0.40% | 271.82 M USD |
Frequently asked questions about Akebia Therapeutics, Inc. - Common Stock
What is the Akebia Therapeutics, Inc. - Common Stock stock price today?
The current price of Akebia Therapeutics, Inc. - Common Stock (AKBA) is 1.37. Over the past 24 hours, the stock has changed by +0.74%. Follow the AKBA chart for real-time price dynamics.
What is the stock ticker of Akebia Therapeutics, Inc. - Common Stock?
Akebia Therapeutics, Inc. - Common Stock trades under the ticker AKBA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Akebia Therapeutics, Inc. - Common Stock stock going up?
AKBA has changed by +15.13% over the last week, +44.21% over the last month, and +16.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Akebia Therapeutics, Inc. - Common Stock net income for the last quarter?
Akebia Therapeutics, Inc. - Common Stock reported net income of -9.05 M for the last quarter. The previous quarter showed -12.24 M, which means net income changed by +26.05%.
How many employees does Akebia Therapeutics, Inc. - Common Stock have?
As of the latest available data, Akebia Therapeutics, Inc. - Common Stock has 194 employees. Workforce size can provide additional context about the company's scale and operations.
What is Akebia Therapeutics, Inc. - Common Stock EBITDA?
Akebia Therapeutics, Inc. - Common Stock EBITDA is -4.37 M, and its EBITDA margin is -8.16%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Akebia Therapeutics, Inc. - Common Stock stock?
You can buy Akebia Therapeutics, Inc. - Common Stock (AKBA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Akebia Therapeutics, Inc. - Common Stock stock?
Investing in Akebia Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AKBA chart and related analysis on metatrader.com as part of your research.